Société des Industries Pharmaceutiques de Tunisie - S.A. Stock
Equities
SIPHA
TN0006670012
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 TND | +4.53% | +4.53% | +4.26% |
Sales 2021 * | 9.51M 3.04M | Sales 2022 * | - | Capitalization | 7.06M 2.25M |
---|---|---|---|---|---|
Net income 2021 * | -22M -7.03M | Net income 2022 * | - | EV / Sales 2021 * | 7.11 x |
Net Debt 2021 * | 60.6M 19.36M | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.32
x | P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 20.01% |
1 day | +4.53% | ||
1 week | +4.53% | ||
Current month | +4.53% | ||
1 month | +4.53% | ||
3 months | +4.26% | ||
6 months | -38.75% | ||
Current year | +4.26% |
Managers | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 17-08-18 |
Emin Cherni
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 17-08-18 |
Wasila Hamami
BRD | Director/Board Member | - | 18-12-31 |
Ridha Saidi
BRD | Director/Board Member | - | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
+4.26% | 2.24M | |
+25.88% | 653B | |
+26.74% | 556B | |
-6.56% | 354B | |
+20.34% | 331B | |
+5.23% | 296B | |
+12.85% | 233B | |
+5.49% | 201B | |
-9.45% | 193B | |
-6.08% | 144B |
- Stock Market
- Equities
- SIPHA Stock